Laboratory Corporation of America Holdings Stock price
Equities
LH
US50540R4092
Healthcare Facilities & Services
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
216.8 USD | +0.12% | +2.93% | -4.32% |
Financials (USD)
Sales 2024 * | 12.76B | Sales 2025 * | 13.29B | Capitalization | 18.21B |
---|---|---|---|---|---|
Net income 2024 * | 1B | Net income 2025 * | 1.13B | EV / Sales 2024 * | 1.77 x |
Net Debt 2024 * | 4.35B | Net Debt 2025 * | 3.86B | EV / Sales 2025 * | 1.66 x |
P/E ratio 2024 * |
18.4
x | P/E ratio 2025 * |
16.4
x | Employees | 61,975 |
Yield 2024 * |
1.37% | Yield 2025 * |
1.41% | Free-Float | 99.74% |
Latest transcript on Laboratory Corporation of America Holdings
1 day | +0.21% | ||
1 week | +2.93% | ||
Current month | +0.76% | ||
1 month | +1.25% | ||
3 months | -4.22% | ||
6 months | +7.00% | ||
Current year | -4.32% |
Managers | Title | Age | Since |
---|---|---|---|
Adam Schechter
CEO | Chief Executive Officer | 59 | 13-03-31 |
Glenn Eisenberg
DFI | Director of Finance/CFO | 62 | 14-06-15 |
Compliance Officer | 65 | 19-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Williams
BRD | Director/Board Member | 75 | 07-05-15 |
Adam Schechter
CEO | Chief Executive Officer | 59 | 13-03-31 |
Director/Board Member | 74 | 95-04-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.97% | 2 M€ | +12.97% | ||
1.95% | 8 M€ | +6.91% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 217.5 | +0.45% | 112 175 |
24-03-27 | 216.6 | +1.43% | 430,701 |
24-03-26 | 213.5 | -0.11% | 559,147 |
24-03-25 | 213.8 | +0.23% | 520,476 |
24-03-22 | 213.3 | +0.93% | 806,721 |
Delayed Quote Nyse, March 28, 2024 at 11:24 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.32% | 18.21B | |
+0.91% | 99.96B | |
+22.40% | 87.73B | |
+10.63% | 29.33B | |
-3.65% | 14.51B | |
+19.48% | 12.22B | |
+31.35% | 12B | |
0.00% | 11.94B | |
-11.65% | 11.63B | |
-32.28% | 11.56B |